colchicine has been researched along with Innate Inflammatory Response in 251 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (19.12) | 18.7374 |
| 1990's | 12 (4.78) | 18.2507 |
| 2000's | 27 (10.76) | 29.6817 |
| 2010's | 75 (29.88) | 24.3611 |
| 2020's | 89 (35.46) | 2.80 |
| Authors | Studies |
|---|---|
| Berridge, MV; Chia, EW; Copp, BR; Denny, WA; Godfrey, CA; Hanton, LR; Harper, JL; Larsen, L; Lu, GL; Pearce, AN; Perry, NB; Sansom, CE; Walton, M; Webb, VL | 1 |
| An, H; Chang, DJ; Jung, JW; Kim, SO; Kim, WJ; Kim, YM; Lee, GB; Suh, YG; Yoon, EY | 1 |
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Benseler, SM; Deschner, N; Kuemmerle-Deschner, JB; Welzel, T; Wildermuth, AL | 1 |
| Byun, HO; Islam, SMS; Jung, JY; Kim, HA; Ryu, HM; Sayeed, HM; Sohn, S; Suh, CH | 1 |
| Li, P; Liu, W; Qu, X; Sun, X | 1 |
| Bouabdallaoui, N; Tardif, JC | 1 |
| Brucato, A; Cantarini, L; Cauli, A; Emmi, G; Fabiani, C; Giacomelli, R; Iannone, F; Lopalco, G; Malandrino, D; Nivuori, M; Parronchi, P; Piga, M; Ruscitti, P; Venerito, V; Vitiello, G | 1 |
| Cole, J; Freilich, M; Htun, N; Layland, J; Lew, R; Quinn, S | 1 |
| Franczyk, B; Gluba-Brzózka, A; Rysz, J; Rysz-Górzyńska, M; Ławiński, J | 1 |
| Fontes-Carvalho, R; Vilela, EM | 1 |
| Esmeray Senol, P; Gezgin Yıldırım, D; Söylemezoğlu, O | 1 |
| Bhatt, DL; Botto, F; Caccavo, A; Castellana, N; Chacón, C; Corral, G; Corral, P; Díaz, ML; Diaz, R; Domínguez, JM; Eikelboom, J; Galatte, A; Gutierrez, O; Jolly, SS; Lamelas, P; Loeb, M; Maggioni, AP; Miró, JM; Orlandini, A; Pascual, A; Rovito, C; Scarafia, F; Sued, O; Yusuf, S | 1 |
| Babyak, A; Biancotto, A; Brady, SM; Chivukula, KK; Dagur, PK; Demidowich, AP; Fantoni, G; Han, JM; Levine, JA; Miller, E; Patel, TP; Periwal, V; Remaley, AT; Sarrafan-Chaharsoughi, Z; Wolska, A; Yanovski, JA | 1 |
| Agnello, F; Capodanno, D | 1 |
| Abbate, A; Bonaventura, A; Cremer, PC; Del Buono, MG; Dentali, F; Imazio, M; Klein, AL; Mauro, AG; Vecchié, A | 1 |
| Tian, F; Wu, B; Xu, T; Yin, X | 1 |
| Abbate, A; Imazio, M | 1 |
| Chen, Q; Dai, C; Gan, J; Gao, J; He, Y; Pan, X; Shen, J | 1 |
| Bruun, JM; Hundahl, MP; Kjolby, M; Kragstrup, TW; Mikkelsen, RR; Rodríguez-Carrio, J; Torp, CK | 1 |
| Acer Kasman, S; Duruöz, MT | 1 |
| Barhdadi, A; Dubé, MP; Hennessy, T; Hillis, GS; Rhainds, D; Schultz, CJ; Sun, M; Tardif, JC | 1 |
| Chen, J; Duan, J; Gu, R; Hu, J; Kang, L; Qi, Y; Shen, S; Wang, K; Wu, X; Xu, B | 1 |
| Bittleman, D; Coras, R; Dadpey, B; Guma, M; Hamilton, B; Lauro, K; Liu-Bryan, R; Mikuls, TR; Quehenberger, O; Reilly, SM; Terkeltaub, R; Thorisdottir, H | 1 |
| Alharthi, F; Althobaiti, F; Chen, X; Mehmood, A; Murtaza, MA; Nadeem, M; Ranjha, MMAN; Shah, AA; Soliman, MM; Usman, M; Wang, C; Zhao, L | 1 |
| Auvens, C; Besancenot, JF; Bielefeld, P; Devilliers, H; El Hssaini, N; Mouries-Martin, S; Muller, G; Rogier, T; Thibault, T; Turcu, A | 1 |
| Li, J; Li, L; Liu, F; Man, X; Tang, J; Wei, Y; Zhang, D | 1 |
| Atalar, E; Ceylan, GG; Doğan, İ; Erten, S; Gök, K; Güven, SC; Maraş, Y | 1 |
| Gülcemal, S; Hakbilen, S; Körez, MK; Onmaz, DE; Sivrikaya, A; Tezcan, D; Yılmaz, S | 1 |
| Blais, J; Bonneville-Roussy, D; Elfassy, HL; Lanthier, S | 1 |
| Colbourne, F; Katsanos, AH; Kung, TFC; Sander, NH; Shoamanesh, A; Wilkinson, CM | 1 |
| Buisan, C; Cebollada, J | 1 |
| Akhter, R; Chow, CK; Church, L; Eberhard, J; Garde, S; King, S | 1 |
| Bellandi, F; Biagini, F; Comeglio, M; Leoncini, M; Magnaghi, G; Maioli, M; Martini, O; Toso, A; Villani, S | 1 |
| Arner, BE; Biancotto, A; Dagur, PK; Demidowich, AP; Elizondo, DM; Famuyiwa, O; Gupta, S; Jain, A; Levine, JA; Lopez-Ocasio, M; McCoy, JP; Patel, TP; Sarrafan-Chaharsoughi, Z; Saxena, A; Yanovski, JA | 1 |
| Agapov, МA; Akopyan, ZA; Asratyan, DA; Begrambekova, YL; Dyachuk, LI; Kamalov, AA; Krasnova, TN; Malahov, PS; Mareev, VY; Mareev, YV; Matskeplishvili, ST; Mershina, EM; Orlova, YA; Pavlikova, EP; Plisuk, AG; Potapenko, AV; Samokhodskaya, LM; Seredenina, EM; Shatokhina, EA; Sinitsyn, VE | 1 |
| Johansen, NJ; Knop, FK | 1 |
| Azmanov, H; Ilan, Y; Kalisman, N; Keidar-Haran, T; Kenig, A; Kessler, A; Kolben, Y; Tayri-Wilk, T; Weksler-Zangen, S | 1 |
| Cimmino, G; Cirillo, P; De Rosa, G; Loffredo, FS | 1 |
| Göker, B; Haznedaroğlu, Ş; Kardaş, RC; Küçük, H; Özkızıltaş, B; Öztürk, MA; Tahta, E; Tufan, A; Vasi, İ; Yıldırım, D | 1 |
| Demirkaya, E; Glazer, S; Karp, N; Richard, K | 1 |
| Bayram, MT; Caglayan, AO; Cankaya, T; Giray Bozkaya, O; Kocabey, M; Ulgenalp, A | 1 |
| Andel, PM; Atar, D; Aukrust, P; Gleditsch, J; Gude, E; Haugeberg, G; Høie, S; Salte, T; Steine, K | 1 |
| Arazi, E; Landau, D; Segev, Y; Shukri, N; Tobar, A | 1 |
| Bustaffa, M; Caorsi, R; Gattorno, M; Lancieri, M; Palmeri, S; Papa, R; Penco, F; Prigione, I; Volpi, S | 1 |
| Aquilani, S; Caldarola, P; Colivicchi, F; De Luca, L; Di Fusco, SA; Gabrielli, D; Gatto, L; Gulizia, MM; Imazio, M; Nardi, F; Oliva, F; Riccio, C; Rizzello, V; Spinelli, A | 1 |
| Abbate, A; Moroni, F | 1 |
| Cronstein, B; Feit, F; Katz, SD; Lorin, JD; Pillinger, MH; Shah, B; Smilowitz, NR; Xia, Y; Zhong, J | 1 |
| Fuster, V; Nelson, K; Ridker, PM | 1 |
| Ananicheva, N; Cherkasova, N; Drogashevskaya, D; Gasanova, D; Komarova, I; Koposova, A; Moiseewa, E; Mukhina, N; Rachina, S; Shchendrygina, A; Sitnikova, V; Smirnova, J; Suvorov, A | 1 |
| Bax, WA; Cornel, JH; El Messaoudi, S; Mohammadnia, N; Opstal, TSJ | 1 |
| Akbaba, TH; Akkaya-Ulum, YZ; Balci-Peynircioğlu, B; Batu, ED; Mutlu, P; Ozen, S; Tümerdem, BŞ | 1 |
| Allahwala, UK; Banning, AP; Bhindi, R; Ciofani, JL; De Maria, GL; Han, D; Nazarzadeh, M; Rahimi, K | 1 |
| Chen, Q; Li, T; Su, Z; Tang, J; Xiong, X; Yang, Q; Zheng, M | 1 |
| Chen, L; Liang, Y; Ren, K; Tong, M; Zhao, GJ; Zhou, HF | 1 |
| Ayaz, NA; Çakan, M; Karadağ, ŞG; Sönmez, HE; Tanatar, A | 1 |
| Moallem, SMH; Mohammadpour, AH; Nomani, H; Sahebkar, A | 1 |
| Douma, S; Papadopoulou-Alataki, E; Papadopoulou-Legbelou, K; Triantafyllou, A; Vampertzi, O | 1 |
| Newby, LK | 1 |
| Johnston, TP; Mohammadpour, AH; Nomani, H; Saei, S; Sahebkar, A | 1 |
| Ridker, PM | 1 |
| Abbasi, J | 1 |
| Holzgreve, H | 1 |
| Djaballah-Ider, F; Touil-Boukoffa, C | 1 |
| Cronstein, B; Feit, F; Katz, SD; Keller, NM; Lorin, JD; Pillinger, M; Ratnapala, N; Shah, B; Smilowitz, NR; Xia, Y; Zhong, H | 1 |
| Cao, D; Chiarito, M; Mehran, R | 1 |
| Whayne, TF | 1 |
| Hernandez, AV; Roman, YM; White, CM | 1 |
| Cardillo, C; De Vito, F; Giustiniani, MC; Manna, R; Schinzari, F; Soldato, M; Talerico, R; Verrecchia, E | 1 |
| Andreou, A; Filippou, D; Sipsas, N; Trantza, S; Tsiodras, S | 1 |
| Alexopoulos, D; Angelidis, C; Baltagiannis, S; Cleman, M; Dangas, G; Davlouros, P; Deftereos, SG; Dolianitis, K; Gargalianos, P; Gerakari, S; Giannopoulos, G; Giotaki, SG; Gogos, C; Goudevenos, J; Hahalis, G; Iliodromitis, E; Kanonidis, I; Katritsis, D; Kolettis, T; Kotanidou, A; Koulouris, NG; Manolis, AS; Martinèz-Dolz, L; Mehran, R; Metallidis, S; Michalis, L; Migdalis, I; Milionis, H; Naka, KK; Olympios, CD; Panagopoulos, P; Pyrgakis, VN; Randou, E; Reimers, B; Sianos, G; Siasos, GD; Sipsas, N; Stefanadis, C; Stefanini, GG; Syrigos, K; Tousoulis, D; Toutouzas, KP; Triposkiadis, F; Tsagalou, E; Tsiodras, S; Tsioufis, K; Tsoukalas, G; Vavouranakis, E; Vrachatis, DA | 1 |
| Adler, Y; Andreis, A; Brucato, A; De Ferrari, GM; Imazio, M; Klein, A; Lazaros, G; Scarsi, M | 1 |
| Camici, GG; Liberale, L; Lüscher, TF; Montecucco, F; Schwarz, L | 1 |
| Akodad, M; Fauconnier, J; Roubille, F; Sicard, P | 1 |
| Arora, S; Behl, T; Bungau, S; Kumar, A; Makkar, R | 1 |
| Alam, M; Jneid, H; Koneru, S; Mahtta, D; Silva, GV; Sudhakar, D; Virani, SS | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Bax, WA; Cornel, JH; de Kleijn, D; Fiolet, ATL; Mosterd, A; Opstal, TSJ; Silvis, MJM; van der Horst, FAL | 1 |
| Coskun Benlidayi, I | 1 |
| Lachmann, HJ; Oldham, J | 1 |
| Duflos, C; Huet, F; Roubille, F | 1 |
| Cornel, JH; Hoogeveen, RM; Stroes, ESG | 1 |
| Barraclough, J; Cochran, BJ; Kavurma, M; Khandkar, C; Kurup, R; Machet, J; Martinez, G; Misra, A; Pandzic, E; Patel, S; Rye, KA; Tucker, B; Vaidya, K | 1 |
| Abbate, A; Dell, M; Ho, AC; Mbualungu, J; VAN Tassell, B; Vecchiè, A | 1 |
| Cheng, Q; Gong, L; He, W; Hu, J; Li, Q; Luo, T; Ma, L; Mei, M; Peng, C; Peng, X; Wang, Y; Wang, Z; Yang, S | 1 |
| Samuel, M; Tardif, JC | 1 |
| Arcudi, A; Borovac, JA; Cappannoli, L; Cappetta, D; Chouchane, K; Crea, F; D'Amario, D; De Angelis, A; Diana, G; Galli, M; Liuzzo, G; Migliaro, S; Montone, RA; Princi, G; Restivo, A; Vergallo, R | 1 |
| Boers, M; Lems, W; Nurmohamed, M; van Vollenhoven, RF | 1 |
| Abdeen, S; Abu-Fanne, R; Bdeir, K; Cines, DB; Deshpande, C; Feldman, M; Heyman, SN; Higazi, AA; Higazi, M; Khurram, N; Litzky, LA; Maraga, E; Montone, KT | 1 |
| Kelly, PJ; Lemmens, R; Tsivgoulis, G | 1 |
| Hota, D; Maiti, R; Sethuramalingam, S; Srinivasan, A | 1 |
| Li, Y; Lu, J; Xie, J; Xu, B; Yin, Y; Zhang, Y | 1 |
| Ahmadi, M; Askari, VR; Baradaran Rahimi, V; Gholoobi, A; Naghedinia, H; Vakili, V | 1 |
| Li, C; Li, Q; Li, Z; Lu, C; Peng, Y; Song, L; Wang, L; Wang, Y; Xia, D; Yu, A | 1 |
| Fan, YX; Gui, X; Han, Y; Hu, L; Jiang, CY; Liu, BQ; Liu, HJ; Liu, WT; Pan, XX; Tang, YL | 1 |
| Ben-Chetrit, E; Bonfrate, L; Palasciano, G; Portincasa, P; Scaccianoce, G | 1 |
| Chung, MJ; Kim, KB; Lee, JH; Lee, JR; Wang, SI | 1 |
| Coveney, S; Kelly, PJ; Lemmens, R; Murphy, S; Price, C; Purroy, F; Tsivgoulis, G | 1 |
| Erken, E | 1 |
| Narula, J; Ridker, PM | 1 |
| Ashchyan, HJ; Gowda, A; James, WD; McMahon, CM; Micheletti, RG; Nelson, CA; Noe, MH; Perl, AE; Rosenbach, M; Wu, B | 1 |
| Brady, RO; Mooney, JJ | 1 |
| Deftereos, S; Giannopoulos, G; Jatuzis, D; Katsanos, AH; Kelly, PJ; Lemmens, R; Panagopoulou, V; Tsivgoulis, G | 1 |
| Celermajer, DS; Martínez, GJ; Patel, S | 2 |
| Chistiakov, DA; Grechko, AV; Melnichenko, AA; Myasoedova, VA; Orekhov, AN | 1 |
| Lafferty, J; O'Herron, T | 1 |
| Chakraborty, B; Chowbay, B; Haaland, B; Huebner, JL; Kraus, VB; Leung, YY; Tan, MH; Thumboo, J; Tjai, M; Wang, C; Wong, SBS | 1 |
| Ghosh, T; Sil, S | 1 |
| Aral, CA; Aral, K; Berdeli, A; Özçoban, Ö; Saraymen, R; Yay, A | 1 |
| Hoss, F; Latz, E | 1 |
| Martínez, G; Patel, S; Vaidya, K | 1 |
| Endo, Y; Fujita, Y; Fukui, S; Hara, K; Ichinose, K; Igawa, T; Ishida, M; Iwamoto, N; Kawakami, A; Kawashiri, SY; Koga, T; Migita, K; Nakamura, H; Nishino, A; Origuchi, T; Shimizu, T; Sumiyoshi, R; Takatani, A; Tamai, M; Tsuji, S; Umeda, M | 1 |
| Cornel, JH; Fiolet, ATL; Mosterd, A; Nidorf, SM | 1 |
| Chatzidou, S; Iliopoulos, DC; Kaminiotis, VV; Kontogiannis, C; Moris, D; Paschou, SA; Siasos, G; Spartalis, E; Spartalis, M; Tsilimigras, DI; Tzatzaki, E; Voudris, V | 1 |
| Nidorf, SM; Thompson, PL | 1 |
| Ozdogan, H; Ugurlu, S | 1 |
| Kavukcu, S; Soylu, A | 1 |
| Dai, P; Danta, M; Furlong, T; Gracie, G; Hetherington, M; Heyworth-Smith, D; Huang, ML; March, L; Phan, TG; Williams, A; Wong, M; Wu, KHC; Yang, T | 1 |
| Ben-David, H; Ben-Zvi, I; Feld, O; Grossman, C; Haj Yahia, S; Lidar, M; Livneh, A | 1 |
| Schulz, C; Stark, K; Stremmel, C | 1 |
| Bowman, M; Hennessy, T; Hillis, GS; Kurup, R; Patel, S; Schultz, C; Soh, L | 1 |
| Bemelman, FJ; Frenkel, J; Potter van Loon, BJ; Simon, A | 1 |
| Eikelboom, JW; Nidorf, SM; Thompson, PL | 2 |
| Anower, AK; Choi, B; Kwon, HJ; Shim, JA; Sohn, S | 1 |
| Dieleman, JM; Jacob, KA; Kluin, J; Nathoe, HM; van Dijk, D; van Osch, D | 1 |
| GRAPPE, JM; MUGLER, A | 1 |
| Akcay, A; Akdeniz, D; Bavbek, N; Ceri, M; Duranay, M; Erdemli, K; Guz, G; Kargili, A | 1 |
| Goker, B; Haznedaroglu, S; Mercan, R; Ozturk, MA; Pasaoglu, H; Pasaoglu, OT; Tufan, A | 1 |
| Horsburgh, S; Robinson, PC | 1 |
| Fürst, R; Zündorf, I | 1 |
| Bardin, T; Doherty, M; Jansen, TL; Nuki, G; Pascual, E; Perez-Ruiz, F; Punzi, L; Richette, P; So, AK | 1 |
| Akarca, US; Aksu, K; Karakose, MZ; Karakose, S; Salman, E; Yapali, S | 1 |
| Bayram, MT; Bora, E; Çankaya, T; Kavukçu, S; Soylu, A; Türkmen, M; Ülgenalp, A | 1 |
| Challita, S; Charpentier, MC; Daher, M; Giraud, F; Guerder, A; Roche, N | 1 |
| Aouba, A; Bienvenu, B; Boue, F; Damaj, G; Decottignies, A; Deshayes, S; Frenzel, L; Georgin-Lavialle, S; Hermine, O; Pressiat, C | 1 |
| Angelini, GD; Ascione, R; James, AF; Suleiman, MS; Zakkar, M | 1 |
| Akdogan, A; Babaoglu, MO; Bertilsson, L; Bozkurt, A; Goktaş, MT; Hatta, F; Helldén, A; Kalkisim, S; Karaca, O; Kilic, L; Yasar, U | 1 |
| Ayvazyan, L; Gasparyan, AY; Kitas, GD; Yessirkepov, M | 1 |
| Allen, N; Berger, JS; Echagarruga, C; Harchandani, B; Karotkin, L; Katz, S; Morina, P; Pillinger, M; Samuels, SK; Sedlis, SP; Shah, B; Singh, P | 1 |
| Acar, B; Başaran, Ö; Çakar, N; Çaycı, FŞ; Uncu, N; Yoldaş, TÇ | 1 |
| Choe, JY; Kim, SK; Park, KY | 1 |
| Abd-Elrahman, I; Abdeen, S; Abu-Fanne, R; Blum, G; Cines, DB; Hankin, A; Higazi, AA; Hijazi, N; Maraga, E | 1 |
| Dhanasekar, C; Kalaiselvan, S; Rasool, M | 1 |
| Alexy, T; Iqbal, A; Mitchell, AJ; Rubinsztain, L; Searles, CD; Shah, AJ; Zafari, AM | 1 |
| Davis, AI; Dedhia, N; Demidowich, AP; Yanovski, JA | 1 |
| Ghosh, R; Ghosh, T; Gupta, P; Kabir, SN; Roy, A; Sil, S | 1 |
| Agrawal, A; Saigal, R | 1 |
| Batu, ED; Bilginer, Y; Özen, S; Sönmez, HE | 1 |
| Anastasiadou, K; Eugenidis, N; Gavalas, E; Giouleme, O; Katsinelos, P; Kountouras, J; Nikolaidis, N; Polyzos, SA; Stefanidis, E; Tzathas, C; Zeglinas, C | 1 |
| Nuki, G | 1 |
| Celik, S; Kucukardali, Y; Nalbant, S; Oktenli, C; Ozgurtas, T; Sahan, B; Sanisoglu, YS; Sayan, O; Solmazgul, E; Tapan, S; Terekeci, HM; Top, C | 1 |
| Bang, D; Choi, B; Kwon, HJ; Lee, ES; Lee, S; Sohn, S | 1 |
| Dhanoa, J; Gera, C; Jose, W; Malhotra, N; Malhotra, V | 1 |
| Akar, S; Akkoc, N; Birlik, M; Onen, F; Sari, I | 1 |
| Han, DS; Han, SH; Jin, R; Jung, DS; Kang, SW; Kim, DK; Kim, SH; Kwak, SJ; Lee, JE; Lee, SH; Li, JJ; Moon, SJ; Ryu, DR; Yoo, TH | 1 |
| Hoffman, HM; Simon, A | 1 |
| Agematsu, K; Masumoto, J; Suzuki, A; Yamazaki, K; Yamazaki, T; Yazaki, M | 1 |
| Foell, D; Kallinich, T; Keitzer, R; Roth, J; Wittkowski, H | 1 |
| Duruöz, MT; Grateau, G | 1 |
| Adhyapak, AA; Ashfaque, SM; Benade, VS; Hebballi, V; Khan, FR; Kulkarni, NM; Mahat, MY; Patil, BM; Thippeswamy, BS; Tubachi, S; Vishwakarma, SL | 1 |
| Joshi, CS; Mathela, CS; Priya, ES | 1 |
| Aggarwal, BB; Chaturvedi, MM; Kannappan, R; Phromnoi, K; Prasad, S; Ravindran, J; Reuter, S; Sung, B; Yadav, VR | 1 |
| Ben-Zvi, I; Livneh, A | 1 |
| Shipley, M | 1 |
| Aggarwal, BB; Gupta, SC; Phromnoi, K; Reuter, S | 1 |
| Brancato, T; Paulis, G | 1 |
| Canzian, M; Fernandes, F; Ianni, BM; Mady, C; Oliveira, AM; Pessoa, FG; Ramires, FJ; Salemi, VM | 1 |
| Dzhndoian, ZT; Martirosian, NG | 1 |
| Amaral, AT; Augusto, O; Brigagão, MR; Cunha, AC; Ferreira, VF; Jordão, AK; Malvezzi, A; Queiroz, RF | 1 |
| Angelidis, C; Bouras, G; Deftereos, S; Doudoumis, K; Driva, M; Efremidis, M; Giannopoulos, G; Kaoukis, A; Kossyvakis, C; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Stefanadis, C; Theodorakis, A | 1 |
| Allaouchiche, B; Floccard, B; Hautin, E; Jacquet-Lagrèze, M; Poutrel, S | 1 |
| Duh, CY; Huang, SY; Jean, YH; Lee, HP; Lin, YY; Wang, HM; Wen, ZH; Wu, SF | 1 |
| Cronstein, BN; Sunkureddi, P | 1 |
| Ahn, HJ; Bang, BK; Cha, JH; Kim, J; Kim, WY; Kim, YS; Li, C; Park, CW; Park, JH; Yang, CW | 1 |
| Ding, A; Mizuochi, T; Odaka, C; Yang, J | 1 |
| KROUTIL, M; LENFELD, J; ZEMANEK, J | 2 |
| BARCELO, P; SANS SOLA, L | 1 |
| AZADIAN-BOULANGER, G; BRANCENI, D; JEQUIER, R | 1 |
| MALAWISTA, SE; SEEGMILLER, JE | 1 |
| Cuisset, L; Delpech, M; Dodé, C; Granel, B; Grateau, G; Hentgen, V | 1 |
| Aldea, A; Arostegui, JI; Campistol, JM; Maso, M; Rius, J; Vives, J; Yagüe, J | 1 |
| Hermesse, A; Leclercq, P; Malaise, MG | 1 |
| Costa, D; Ghio, A; Lehmann, J; Richards, J; Winsett, D | 1 |
| Acar, B; Ekim, M; Gökmen, D; Ozçakar, ZB; Yalçinkaya, F; Yüksel, S | 1 |
| Onen, F | 1 |
| Martinon, F; Mayor, A; Pétrilli, V; Tardivel, A; Tschopp, J | 1 |
| Niel, E; Scherrmann, JM | 1 |
| Pope, RM; Tschopp, J | 1 |
| Bernardo, J; Center, DM; Kaelin, RM; Semerjian, A | 1 |
| Moncada, S; Salmon, JA; Simmons, PM | 1 |
| Brandwein, SR; Cohen, AS; Sipe, JD; Skinner, M; Tatsuta, E | 1 |
| Godeau, P; Hartmann, L; Ollier-Hartmann, MP | 1 |
| Higgs, GA; Moncada, S; Salmon, JA; Seager, K | 1 |
| Malkinson, FD | 1 |
| Wilkinson, PC | 1 |
| Ehrenfeld, M; Eliakim, M; Gallily, R; Levy, M | 1 |
| Horrobin, DF | 1 |
| Denko, CW; Petricevic, M | 1 |
| Croxton, TL; Kleeberger, SR; Takahashi, M | 1 |
| Fener, P; Gillet, P; Jouzeau, JY; Netter, P | 1 |
| Alcaraz, MJ; Ferrándiz, ML; Payá, M; Terencio, MC | 1 |
| Itoh, N; Kasamatsu, M; Muto, N; Onosaka, S; Tanaka, K | 1 |
| Alcaraz, MJ; Coloma, J; García Pastor, P; Payá, M | 1 |
| Tunca, M | 1 |
| Ben-Chetrit, E; Levy, M | 1 |
| Franklin, E; MacArthur, L; Pfaffenroth, E; Ren, K; Ruda, MA | 1 |
| Abrams, T; Monfils, P; Raymond, RM; Salness, R; Wang, RY | 1 |
| Alcaraz, MJ; Coloma, J; Ferrándiz, ML; Guillén, I; Payá, M; Posadas, I; Terencio, MC | 1 |
| Bertsch, T; Fassbender, K; Fatar, M; Hennerici, M; Kischka, U; Kühl, S; Ragoschke, A; Schlueter, D; Schneider, S | 1 |
| Danon, YL; Fischel-Ghodsian, N; Halpern, GJ; Krasnov, M; Magal, N; Mimouni, A; Minasian, A; Rotter, JI; Shohat, M; Shohat, T; Stoffman, N | 1 |
| Arnaud, M; Denes, E; Gissot, V; Loustaud, V; Pascaud, JL; Vidal, E | 1 |
| Itoh, M; Konemura, T; Kuraishi, Y; Sasaki, M; Sasamura, T; Tohda, C | 1 |
| Amolsky, D; Buskila, D; Langevitz, P; Livneh, A; Neumann, L; Pras, M; Shemer, J | 1 |
| Stevenson, RD | 1 |
| Chang, YH | 1 |
| Bradshaw, D; Giroud, JP; Roch-Arveiller, M | 1 |
| Denko, CW | 2 |
| Perper, RJ | 1 |
| Borel, JF; Feurer, C | 1 |
| Brune, K; Kälin, H | 1 |
| Feldmann, G; Kushner, I | 1 |
| Dry, J | 1 |
| Denko, CW; Whitehouse, MW | 2 |
| Ebe, T; Hibiya, I; Ikemoto, H; Inagaki, M; Isonuma, H; Kohara, T; Mori, T; Takahashi, M; Watanabe, K | 1 |
| Blackham, A; Griffiths, RJ; Li, SW; Wood, BE | 1 |
| Griswold, DE; Hillegass, LM; Webb, EF | 1 |
| Hambleton, P; Miller, P | 1 |
| Wahl, LM; Wahl, SM | 1 |
| McCarty, DJ | 3 |
| Brooks, PM; Burton, D; Forrest, MJ | 1 |
| Botting, R; Vane, J | 1 |
| Lees, P; Sedgwick, AD | 1 |
| Brandwein, SR; Cohen, AS; Sipe, JD; Skinner, M | 1 |
| Phelps, P; Tse, RL | 1 |
| Richardson, KT | 1 |
| Hoffstein, S; Weissmann, G; Zurier, RB | 1 |
| Chinea, G; Oronsky, AL; Perper, RJ; Sanda, M | 1 |
| Mariano, M; Spector, WG | 1 |
| Paupe, J | 1 |
| McCarty, DJ; Steele, AD | 1 |
| Goth, A | 1 |
| Cline, MJ; Melmon, KL | 1 |
| Malawista, SE | 1 |
| Caner, JE | 1 |
73 review(s) available for colchicine and Innate Inflammatory Response
| Article | Year |
|---|---|
Emerging Anti-Atherosclerotic Therapies.
Topics: Adaptive Immunity; Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Colchicine; Humans; Immunity, Innate; Inflammation; Interleukin-1beta; P-Selectin; p38 Mitogen-Activated Protein Kinases; Risk Factors | 2021 |
Inflammation and ischemic heart disease: The next therapeutic target?
Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Humans; Inflammation; Myocardial Ischemia | 2021 |
Advances in pharmacotherapy for acute and recurrent pericarditis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Humans; Inflammasomes; Inflammation; Pericarditis | 2022 |
Interventions for reducing inflammation in familial Mediterranean fever.
Topics: Adolescent; Adult; Amyloidosis; Child; Child, Preschool; Colchicine; Familial Mediterranean Fever; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Middle Aged; Serum Amyloid A Protein; Young Adult | 2022 |
The inflammasome as a therapeutic target for myopericardial diseases.
Topics: Colchicine; Humans; Inflammasomes; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein; Pericarditis | 2022 |
Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: A bedside-to-bench approach.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Etanercept; Humans; Hydroxychloroquine; Immunomodulating Agents; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-1beta; Methotrexate; Sulfasalazine | 2022 |
[Colchicine and non-severe ocular inflammation excluding Behcet's disease: 16 cases and literature review].
Topics: Behcet Syndrome; Colchicine; Female; Humans; Inflammation; Male; Recurrence; Scleritis; Uveitis; Uveitis, Anterior; Vision Disorders | 2022 |
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence.
Topics: Acute Coronary Syndrome; Colchicine; Humans; Inflammation; Pericarditis; Thrombosis | 2023 |
An Update on Familial Mediterranean Fever.
Topics: Amyloidosis; Child; Colchicine; Diagnosis, Differential; Familial Mediterranean Fever; Fever; Humans; Inflammation | 2023 |
Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week.
Topics: Adult; Atherosclerosis; Cholesterol, LDL; Colchicine; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Myocardial Infarction; Secondary Prevention | 2023 |
An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Biomarkers; Colchicine; Humans; Inflammasomes; Inflammation; Lipids | 2023 |
Anti-inflammatory drugs in the prevention of post-operative atrial fibrillation: a literature review.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Colchicine; Humans; Inflammation; Postoperative Complications | 2020 |
Familial Mediterranean fever and atherosclerosis in childhood and adolescence.
Topics: Adolescent; Albuminuria; Asymptomatic Diseases; Atherosclerosis; Carotid Intima-Media Thickness; Child; Cholesterol, HDL; Colchicine; Echocardiography; Endothelium, Vascular; Familial Mediterranean Fever; Humans; Inflammation; Neoplasm Proteins; Proteoglycans; Pulse Wave Analysis; Stroke Volume; Triglycerides; Tubulin Modulators | 2020 |
The Efficacy of Anti-inflammatory Agents in the Prevention of Atrial Fibrillation Recurrences.
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Colchicine; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Recurrence; Steroids; Treatment Outcome | 2021 |
Topics: Colchicine; Humans; Inflammation; Myocardial Infarction | 2020 |
Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication?
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Heart Disease Risk Factors; Humans; Inflammation | 2021 |
The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Female; Humans; Immunity, Innate; Inflammation; Male; Methotrexate; Middle Aged; Treatment Outcome | 2020 |
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Topics: Acetylcysteine; Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Autophagy; Betacoronavirus; Colchicine; Copper; Coronavirus Infections; COVID-19; Cytidine; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxylamines; Inflammation; Nitric Oxide; Pandemics; Pneumonia, Viral; Prodrugs; Ribonucleosides; SARS-CoV-2; Virus Internalization; Virus Replication | 2020 |
Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
Topics: Anti-Inflammatory Agents; Betacoronavirus; Colchicine; Comorbidity; Coronavirus Infections; COVID-19; Duration of Therapy; Glucocorticoids; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Pandemics; Pericarditis; Pneumonia, Viral; Receptors, Interleukin-1; SARS-CoV-2 | 2020 |
Inflammation and cardiovascular diseases: lessons from seminal clinical trials.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Atherosclerosis; Colchicine; Evidence-Based Medicine; Humans; Inflammation; Inflammation Mediators; Randomized Controlled Trials as Topic; Research Design; Signal Transduction; Thrombosis; Treatment Outcome | 2021 |
Colchicine and myocardial infarction: A review.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; Humans; Inflammation; Inflammation Mediators; Myocardial Infarction; Myocarditis; Myocardium; Signal Transduction; Treatment Outcome | 2020 |
Understanding the Role of Inflammasomes in Rheumatoid Arthritis.
Topics: Animals; Arthritis, Gouty; Arthritis, Rheumatoid; Autoimmune Diseases; Colchicine; Cytokines; Epitopes; Humans; Immune System; Immunity, Innate; Immunoglobulin G; Inflammasomes; Inflammation; Lupus Erythematosus, Systemic; Mice; NLR Proteins; Spondylarthritis; Spondylitis, Ankylosing | 2020 |
Targeting Inflammation After Myocardial Infarction.
Topics: Colchicine; Humans; Inflammation; Myocardial Infarction | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples.
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Colchicine; Cryopyrin-Associated Periodic Syndromes; Dermatologists; Familial Mediterranean Fever; Fever; Hereditary Autoinflammatory Diseases; Humans; Immune System Diseases; Immunity, Innate; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Mevalonate Kinase Deficiency; Receptors, Interleukin-1; Receptors, Interleukin-6; Schnitzler Syndrome; Skin Diseases, Genetic; Steroids; Tubulin Modulators | 2020 |
Colchicine in ischemic heart disease: the good, the bad and the ugly.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Inflammation; Myocardial Ischemia; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic | 2021 |
Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Cardiovascular Diseases; Colchicine; Humans; Inflammation | 2021 |
Inflammation and Stroke Risk: A New Target for Prevention.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; Drug Delivery Systems; Gout Suppressants; Humans; Inflammation; Mendelian Randomization Analysis; Observational Studies as Topic; Risk Factors; Secondary Prevention; Stroke | 2021 |
Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A Meta-analysis of Clinical Trials.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Coronary Artery Disease; Heart Disease Risk Factors; Humans; Inflammation; Myocardial Infarction; Risk Factors | 2023 |
Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Humans; Inflammasomes; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein; Plaque, Atherosclerotic | 2021 |
Anti-inflammatory approaches to ischaemic stroke prevention.
Topics: Anti-Inflammatory Agents; Brain Ischemia; C-Reactive Protein; Colchicine; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Intracranial Arteriosclerosis; Plaque, Atherosclerotic; Recurrence; Stroke | 2018 |
Cardiac disease in familial Mediterranean fever.
Topics: Amyloidosis; Cardiovascular Diseases; Colchicine; Familial Mediterranean Fever; Genotype; Humans; Immunosuppressive Agents; Inflammation; Phenotype; Tubulin Modulators; Vasculitis | 2018 |
Lithium + Colchicine: A Potential Strategy to Reduce Pro-inflammatory Effects of Lithium Treatment.
Topics: Anti-Inflammatory Agents; Bipolar Disorder; Colchicine; Cytokines; Dose-Response Relationship, Drug; Humans; Inflammation; Lithium Compounds; Patient Acceptance of Health Care; Treatment Outcome | 2018 |
The Role of Colchicine in the Prevention of Cerebrovascular Ischemia.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Brain Ischemia; Colchicine; Gout Suppressants; Humans; Inflammation | 2018 |
The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
Topics: Animals; Anti-Inflammatory Agents; Arteries; Atherosclerosis; Colchicine; Cytokines; Humans; Inflammasomes; Inflammation; Inflammation Mediators; Macrophages; Monocytes; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein; Plaque, Atherosclerotic; Signal Transduction | 2018 |
Potential of anti-inflammatory agents for treatment of atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Atherosclerosis; Colchicine; Cyclooxygenase 2 Inhibitors; Cytokines; Humans; Inflammation; Leukotrienes; Methotrexate; Molecular Targeted Therapy; Phospholipase A2 Inhibitors; Signal Transduction | 2018 |
The Role of Colchicine in Acute Coronary Syndromes.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Cytokines; Humans; Inflammation; Monocytes | 2019 |
Colchicine in Stable Coronary Artery Disease.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Gout; Humans; Inflammation; Myocardial Infarction; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention | 2019 |
The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
Topics: Acute Coronary Syndrome; Animals; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Myocardial Infarction; Plaque, Atherosclerotic | 2018 |
Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Cytokines; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1beta; Secondary Prevention | 2019 |
Familial Mediterranean Fever.
Topics: Age of Onset; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Colchicine; Familial Mediterranean Fever; Female; Genetic Association Studies; Humans; Immunity, Innate; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Male; Pregnancy; Pregnancy Complications; Pyrin | 2019 |
Toll-like receptor 2 is overexpressed in Familial Mediterranean fever patients and is inhibited by colchicine treatment.
Topics: Colchicine; Familial Mediterranean Fever; Humans; Inflammation; Monocytes; Toll-Like Receptor 2; Tubulin Modulators; Up-Regulation | 2018 |
Heterogeneity of Macrophages in Atherosclerosis.
Topics: Animals; Atherosclerosis; Cell Adhesion; Colchicine; Humans; Immune System; Inflammation; Lipoproteins, LDL; Macrophages; Mice; Monocytes; Phagocytosis; Phenotype; Treatment Outcome | 2019 |
[Familial Mediterranean fever: not to be missed].
Topics: Adolescent; Adult; Amyloidosis; Child, Preschool; Colchicine; Familial Mediterranean Fever; Female; Humans; Inflammation; Interleukin-1; Morocco; Mutation; Netherlands; Tubulin Modulators; Turkey | 2013 |
Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Cholesterol; Colchicine; Crystallization; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Macrophages; Molecular Targeted Therapy; Neutrophils; Plaque, Atherosclerotic; Secondary Prevention | 2014 |
Inflammation in new-onset atrial fibrillation after cardiac surgery: a systematic review.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Atrial Fibrillation; Biomarkers; Cardiac Surgical Procedures; Colchicine; Epidemiologic Methods; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Postoperative Complications; Steroids; Vitamins | 2014 |
Colchicine for secondary prevention of cardiovascular disease.
Topics: Acute Coronary Syndrome; Clinical Trials as Topic; Colchicine; Coronary Artery Disease; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Secondary Prevention; Time; Treatment Outcome | 2014 |
Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colchicine; Gout; Gout Suppressants; Humans; Hyperuricemia; Inflammation; Interleukin-1; Joints; Uric Acid | 2014 |
Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress.
Topics: Animals; Anti-Inflammatory Agents; Capsaicin; Catechin; Colchicine; Curcumin; Humans; Imidazoles; Inflammation; Niacin; Resveratrol; Stilbenes | 2014 |
Improving cardiovascular and renal outcomes in gout: what should we target?
Topics: Allopurinol; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Disease Management; Gout; Gout Suppressants; Humans; Hyperuricemia; Inflammation; Metabolic Syndrome; Probenecid; Renal Insufficiency, Chronic; Treatment Outcome; Uricosuric Agents; Xanthine Oxidase | 2014 |
Efficacy of anakinra for various types of crystal-induced arthritis in complex hospitalized patients: a case series and review of the literature.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Gouty; C-Reactive Protein; Colchicine; Comorbidity; Female; Glucocorticoids; Hospitalization; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Male; Retrospective Studies; Treatment Outcome | 2015 |
Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery.
Topics: Adrenal Cortex Hormones; Ascorbic Acid; Atrial Fibrillation; Cardiac Surgical Procedures; Colchicine; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Myocardial Reperfusion Injury; Oxidative Stress; Postoperative Complications; Reactive Oxygen Species; Risk Factors; Systemic Inflammatory Response Syndrome; Vitamin E | 2015 |
Colchicine as an anti-inflammatory and cardioprotective agent.
Topics: Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Cardiovascular Diseases; Colchicine; Diarrhea; Humans; Inflammation | 2015 |
Pathogenesis and Clinical Management of Gouty Arthritis.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Gouty; Colchicine; Diet, Healthy; Febuxostat; Fluid Therapy; Gout Suppressants; Humans; Hyperuricemia; Inflammation; Interleukin 1 Receptor Antagonist Protein; Polyethylene Glycols; Smoking Cessation; Urate Oxidase; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2015 |
Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.
Topics: Animals; Arthritis, Gouty; Chondrocalcinosis; Colchicine; Disease Models, Animal; Gout Suppressants; Inflammation | 2008 |
Recurrent febrile syndromes: what a rheumatologist needs to know.
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Familial Mediterranean Fever; Fatigue; Fever; Glucocorticoids; Humans; Inflammation; Kidney Diseases; Periodicity; Professional Practice; Rheumatology; Syndrome | 2009 |
[Familial Mediterranean fever as representative autoinflammatory disease].
Topics: Amyloidosis; Colchicine; Cytoskeletal Proteins; Exons; Familial Mediterranean Fever; Gene Frequency; Humans; Inflammation; Interleukin-1; Mutation; Polymorphism, Genetic; Pyrin | 2009 |
Autoinflammatory conditions: when to suspect? How to treat?
Topics: Amyloidosis; Autoimmune Diseases; Colchicine; Familial Mediterranean Fever; Genetic Predisposition to Disease; Hereditary Autoinflammatory Diseases; Humans; Inflammation; Interleukin-1; Syndrome | 2010 |
Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.
Topics: Biomarkers; Chronic Disease; Colchicine; Familial Mediterranean Fever; Gout Suppressants; Humans; Inflammation; Risk Factors; Serum Amyloid A Protein | 2011 |
Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies.
Topics: Animals; Colchicine; Humans; Inflammation; Male; Oxidative Stress; Penile Induration; Penis; Reactive Oxygen Species; Treatment Outcome; Verapamil; Vitamin E | 2012 |
Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Carrier Proteins; Colchicine; Disease Management; Glucocorticoids; Gout Suppressants; Humans; Inflammation; Interleukin-1beta; NLR Family, Pyrin Domain-Containing 3 Protein | 2013 |
[Tumor necrosis factor receptor superfamily 1A-associated periodic syndrome (TRAPS)].
Topics: Abdominal Pain; Amyloid; Antigens, CD; Apoptosis; Colchicine; Diagnosis, Differential; Erythema; Familial Mediterranean Fever; Gout Suppressants; Humans; Inflammation; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha | 2003 |
[Familial Mediterranean fever].
Topics: Amyloidosis; Colchicine; Cytoskeletal Proteins; Familial Mediterranean Fever; Gout Suppressants; Humans; Incidence; Inflammation; Proteins; Pyrin; Renal Insufficiency | 2004 |
Familial Mediterranean fever.
Topics: Amyloidosis; Arabs; Colchicine; Cytoskeletal Proteins; Diagnosis, Differential; Ethnicity; Familial Mediterranean Fever; Humans; Inflammation; Jews; Kidney Diseases; Mutation; Prevalence; Pyrin; Risk Factors | 2006 |
Colchicine today.
Topics: Colchicine; Gout; Gout Suppressants; Humans; Inflammation | 2006 |
The role of interleukin-1 and the inflammasome in gout: implications for therapy.
Topics: Animals; Arthritis, Gouty; Carrier Proteins; Colchicine; Gout; Gout Suppressants; Humans; Hyperuricemia; Inflammation; Interleukin-1beta; Macrophages; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Toll-Like Receptors; Uric Acid | 2007 |
Colchicine. New uses of an old, old drug.
Topics: Colchicine; Familial Mediterranean Fever; Gout; Humans; Inflammation; Neoplasms; Skin Diseases | 1982 |
The measurement of leucocyte chemotaxis.
Topics: Cell Adhesion; Cell Communication; Cell Count; Cell Movement; Chemotaxis, Leukocyte; Cineradiography; Colchicine; Dose-Response Relationship, Immunologic; Fibroblasts; Humans; Inflammation; Micropore Filters; Neutrophils; Sepharose; Stimulation, Chemical; Videotape Recording | 1982 |
Periodic fever compatible with familial Mediterranean fever.
Topics: Abdominal Pain; Back Pain; Chest Pain; Colchicine; Familial Mediterranean Fever; Humans; Inflammation; Japan; Leukocytosis; Male; Middle Aged; Norepinephrine; Pleural Effusion | 1992 |
Arthritis associated with crystals containing calcium.
Topics: Aged; Anti-Inflammatory Agents; Arthritis; Calcium Phosphates; Calcium Pyrophosphate; Colchicine; Crystallization; Diphosphates; Female; Humans; Hyperplasia; Inflammation; Joint Diseases; Methods; Peptide Hydrolases; Radiography; Shoulder Joint; Syndrome; Synovial Membrane | 1986 |
Inflammation and the mechanism of action of anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Bradykinin; Colchicine; Cyclooxygenase Inhibitors; Gold; Histamine; Humans; Inflammation; Interleukin-1; Lipoxygenase Inhibitors; Platelet Activating Factor; Salicylates | 1987 |
Pharmacology and pathophysiology of inflammation.
Topics: Antibody Formation; Antigen-Antibody Reactions; Antilymphocyte Serum; Colchicine; Humans; Hydrocortisone; Hypersensitivity, Delayed; Immunity, Cellular; Immunoglobulin A; Immunoglobulin D; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Lymphocytes; Lysosomes; Methotrexate; Microbial Collagenase; Nitrogen Mustard Compounds; Phagocytosis; Recurrence; Transplantation Immunology | 1971 |
Crystal-induced inflammation of the joints.
Topics: Animals; Arthritis; Colchicine; Dogs; Gout; Humans; Inflammation; Leukocytes; Phagocytosis; Uric Acid | 1970 |
21 trial(s) available for colchicine and Innate Inflammatory Response
| Article | Year |
|---|---|
COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): A Descriptive Cytokine Pilot Sub-Study.
Topics: Biomarkers; C-Reactive Protein; Colchicine; Cytokines; Heart Injuries; Humans; Inflammation; Percutaneous Coronary Intervention; Pilot Projects; Troponin | 2022 |
Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Colchicine; COVID-19; Female; Hospitalization; Humans; Inflammation; Intubation, Intratracheal; Male; Middle Aged; Respiration, Artificial; SARS-CoV-2; Standard of Care | 2021 |
Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome.
Topics: Adipose Tissue; Adult; Biomarkers; Colchicine; Humans; Inflammation; Insulin; Insulin Resistance; Lipolysis; Metabolic Syndrome; Obesity | 2022 |
Effect of Baihu and Guizhi decoction in acute gouty arthritis: study protocol for a randomized controlled trial.
Topics: Adult; Arthralgia; Arthritis, Gouty; Colchicine; Double-Blind Method; Drugs, Chinese Herbal; Humans; Inflammation; Randomized Controlled Trials as Topic; Spasm; Treatment Outcome | 2022 |
Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
Topics: Biomarkers; C-Reactive Protein; Colchicine; Humans; Inflammation; Myocardial Infarction | 2022 |
Targeting the reduction of inflammatory risk associated with cardiovascular disease by treating periodontitis either alone or in combination with a systemic anti-inflammatory agent: protocol for a pilot, parallel group, randomised controlled trial.
Topics: Anti-Inflammatory Agents; C-Reactive Protein; Cardiovascular Diseases; Colchicine; Humans; Inflammation; Lipids; Periodontitis; Randomized Controlled Trials as Topic; Single-Blind Method; Treatment Outcome | 2022 |
Rationale and design of COLchicine On-admission to Reduce inflammation in Acute Coronary Syndrome (COLOR-ACS) study.
Topics: Acute Coronary Syndrome; Atorvastatin; C-Reactive Protein; Colchicine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Treatment Outcome | 2023 |
Immunomodulatory effects of colchicine on peripheral blood mononuclear cell subpopulations in human obesity: Data from a randomized controlled trial.
Topics: Adult; Colchicine; Fatty Acid-Binding Proteins; Humans; Inflammation; Leukocytes, Mononuclear; Obesity | 2023 |
Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel
Topics: Anti-Inflammatory Agents; Colchicine; COVID-19; Cytokines; Humans; Inflammation; Inpatients; Prospective Studies; RNA, Viral; SARS-CoV-2; Treatment Outcome | 2022 |
Major Adverse Cardiovascular Events After Colchicine Administration Before Percutaneous Coronary Intervention: Follow-Up of the Colchicine-PCI Trial.
Topics: Acute Coronary Syndrome; Colchicine; Follow-Up Studies; Humans; Inflammation; Percutaneous Coronary Intervention; Treatment Outcome | 2023 |
Colchicine in patients with heart failure and preserved left ventricular ejection fraction: rationale and design of a prospective, randomised, open-label, crossover clinical trial.
Topics: C-Reactive Protein; Colchicine; Heart Failure; Humans; Inflammation; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2023 |
Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.
Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Colchicine; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Middle Aged; New York City; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Stents; Time Factors; Treatment Outcome | 2020 |
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Betacoronavirus; C-Reactive Protein; Cause of Death; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diarrhea; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Greece; Hospitalization; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Time Factors; Treatment Outcome; Troponin; Tubulin Modulators | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein.
Topics: Aged; Biomarkers; C-Reactive Protein; Chronic Disease; Colchicine; Coronary Artery Disease; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Inflammation; Leukocyte Count; Lipid Metabolism; Male; Middle Aged; Platelet Count; Prospective Studies; Treatment Outcome | 2020 |
Low-dose colchicine in type 2 diabetes with microalbuminuria: A double-blind randomized clinical trial.
Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Colchicine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Inflammation; Male; Middle Aged; Neutrophils; Placebos | 2021 |
Alpha-defensins: risk factor for thrombosis in COVID-19 infection.
Topics: Adult; Aged; alpha-Defensins; Animals; Blood Coagulation; Case-Control Studies; Colchicine; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Inflammation; Interleukin-6; Male; Mice; Middle Aged; Models, Animal; Neutrophils; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Thromboembolism; Thrombosis; Tubulin Modulators | 2021 |
Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Colchicine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Non-ST Elevated Myocardial Infarction | 2021 |
Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Colchicine; Cytokines; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Inflammation; Male; Middle Aged; Osteoarthritis, Knee; Synovial Fluid; Treatment Outcome; Young Adult | 2018 |
Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study.
Topics: Aged; Arrhythmias, Cardiac; Atrial Fibrillation; C-Reactive Protein; Colchicine; Double-Blind Method; Female; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Odds Ratio; Placebos; Pulmonary Veins; Recurrence; Treatment Outcome; Tubulin Modulators | 2012 |
An experimental model of acute inflammation in man.
Topics: Adult; Aspirin; Clinical Trials as Topic; Colchicine; Humans; Inflammation; Knee Joint; Male; Methylprednisolone; Models, Theoretical; Phenylbutazone; Placebos; Prednisolone; Uric Acid | 1966 |
158 other study(ies) available for colchicine and Innate Inflammatory Response
| Article | Year |
|---|---|
Synthesis and anti-inflammatory structure-activity relationships of thiazine-quinoline-quinones: inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Cell Proliferation; Disease Models, Animal; HL-60 Cells; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Neutrophils; Quinolines; Quinones; Respiratory Burst; Structure-Activity Relationship; Superoxides; Thiazines | 2008 |
Design, synthesis and identification of novel colchicine-derived immunosuppressant.
Topics: Animals; Autoimmune Diseases; Chemistry, Pharmaceutical; Colchicine; Cyclosporine; Drug Design; Gout Suppressants; Graft Rejection; Humans; Immunosuppressive Agents; Inflammation; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Rats; Skin Transplantation; Structure-Activity Relationship | 2009 |
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Colchicine - an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants.
Topics: Child; Child, Preschool; Cohort Studies; Colchicine; Female; Humans; Infant; Inflammation; Male; Pilot Projects; Treatment Outcome | 2021 |
Topics: Administration, Oral; Adult; Animals; Antigens, CD; Bacteria; Behcet Syndrome; Butyrates; CD83 Antigen; Colchicine; Combined Modality Therapy; Dendritic Cells; Disease Models, Animal; Down-Regulation; Eubacterium; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunoglobulins; Inflammation; Interleukin-17; Killer Cells, Natural; Male; Membrane Glycoproteins; Metagenome; Mice; Middle Aged; Random Allocation; Ribotyping; RNA, Ribosomal, 16S; Severity of Illness Index | 2021 |
Isovitexin alleviates acute gouty arthritis in rats by inhibiting inflammation via the TLR4/MyD88/NF-κB pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apigenin; Arthritis, Gouty; Colchicine; Disease Models, Animal; Inflammation; Male; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Sulfonamides; Toll-Like Receptor 4 | 2021 |
Repurposing Colchicine for Heart Disease.
Topics: Atrial Fibrillation; Colchicine; Coronary Artery Disease; Humans; Inflammation; Pericarditis | 2022 |
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study.
Topics: Adult; Colchicine; Female; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Middle Aged; Pericarditis; Recurrence; Retrospective Studies; Treatment Outcome | 2022 |
Predictors of persistent inflammation in children with familial Mediterranean fever.
Topics: Arthritis; Chest Pain; Child; Colchicine; Erysipelas; Erythema; Familial Mediterranean Fever; Humans; Inflammation; Mutation; Pyrin; Retrospective Studies | 2022 |
Anti-inflammatory strategies for atherosclerotic artery disease.
Topics: Anti-Inflammatory Agents; Arteries; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Inflammation | 2022 |
Seasonal residual activity in adult familial Mediterranean fever: a longitudinal observational study.
Topics: Adult; Arthralgia; Arthritis; Colchicine; Familial Mediterranean Fever; Humans; Inflammation; Longitudinal Studies; Seasons | 2022 |
Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction.
Topics: Animals; Arrhythmias, Cardiac; Colchicine; Fibrosis; Heart Failure; Inflammation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Stroke Volume | 2022 |
Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes.
Topics: Adipocytes; Allopurinol; Colchicine; Enzyme Inhibitors; Fatty Acids, Nonesterified; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Inflammation; Lipolysis; Prospective Studies; Uric Acid; Xanthine Oxidase | 2022 |
Anti-inflammatory potential of stevia residue extract against uric acid-associated renal injury in mice.
Topics: Allopurinol; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Colchicine; Creatinine; Drugs, Chinese Herbal; Gout; Humans; Hyperuricemia; Inflammation; Interleukin-18; Interleukin-6; Kidney; Mice; NF-E2-Related Factor 2; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; RNA, Messenger; Sirtuin 1; Stevia; Tumor Necrosis Factor-alpha; Uric Acid | 2022 |
Colchicine improves severe acute pancreatitis-induced acute lung injury by suppressing inflammation, apoptosis and oxidative stress in rats.
Topics: Acute Disease; Acute Lung Injury; Animals; Apoptosis; Colchicine; Inflammation; Male; NF-kappa B; Oxidative Stress; Pancreatitis; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2022 |
The effectiveness of anti-interleukin-1 therapy on subclinical inflammation parameters during the attack-free period in familial Mediterranean fever patients: A case-control study.
Topics: Amyloidosis; C-Reactive Protein; Case-Control Studies; Colchicine; Familial Mediterranean Fever; Fibrinogen; Hemoglobins; Humans; Inflammation | 2022 |
Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever.
Topics: Biomarkers; Case-Control Studies; Colchicine; Familial Mediterranean Fever; Humans; Inflammation; Leukocyte L1 Antigen Complex; Neopterin | 2023 |
Ischemic stroke is a potential complication of uncontrolled inflammation in mevalonate kinase deficiency - A case report.
Topics: Adult; Canada; Child; Colchicine; Exanthema; Fever; Humans; Infant; Inflammation; Ischemic Stroke; Lymphadenopathy; Male; Mevalonate Kinase Deficiency | 2022 |
Colchicine pre-treatment and post-treatment does not worsen bleeding or functional outcome after collagenase-induced intracerebral hemorrhage.
Topics: Animals; Brain Injuries; Cerebral Hemorrhage; Clinical Trials, Phase II as Topic; Colchicine; Collagenases; Disease Models, Animal; Fibrinolytic Agents; Inflammation; Rats | 2022 |
Therapeutic role of colchicine in reducing cardiovascular risk associated with inflammation.
Topics: Cardiovascular Diseases; Colchicine; Heart Disease Risk Factors; Humans; Inflammation; Risk Factors | 2022 |
The potential of colchicine for lowering the risk of cardiovascular events in type 1 diabetes.
Topics: Atherosclerosis; Brain Ischemia; Colchicine; Diabetes Mellitus, Type 1; Humans; Inflammation; Stroke | 2023 |
Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation.
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Colchicine; Cytokines; Inflammation; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Proteomics; Sepsis | 2023 |
Factors affecting patient-acceptable symptom states and treatment decision in familial Mediterranean fever.
Topics: Adult; Colchicine; Familial Mediterranean Fever; Female; Humans; Inflammation; Interleukin-1; Male; Middle Aged; Quality of Life | 2022 |
A young woman with fever and polyserositis caused by familial Mediterranean fever.
Topics: Chronic Disease; Colchicine; Familial Mediterranean Fever; Female; Fever; Humans; Inflammation | 2023 |
Investigation of different genomic variants in familial Mediterranean fever cases with monoallelic MEFV mutation.
Topics: Amyloidosis; Colchicine; Familial Mediterranean Fever; Genomics; Humans; Inflammation; Mutation; Pyrin | 2023 |
Recurrent pericarditis.
Topics: Colchicine; Humans; Inflammation; Myocardial Infarction; Pericarditis; Recurrence | 2023 |
Beneficiary Effects of Colchicine on Inflammation and Fibrosis in a Mouse Model of Kidney Injury.
Topics: Adenine; Animals; Anti-Inflammatory Agents; Caspase 1; Colchicine; Disease Models, Animal; Fibrosis; Inflammation; Interleukin-1; Kidney; Mice; Mice, Inbred C57BL; Renal Insufficiency, Chronic; Tubulin | 2023 |
[ANMCO Position paper: Colchicine as a therapeutic agent in coronary syndromes].
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Humans; Inflammation | 2023 |
Anti-inflammatory (Colchicine) Treatment for Secondary Prevention in Coronary Artery Disease: A Milestone has Been Met.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Inflammation; Secondary Prevention | 2023 |
Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients.
Topics: Colchicine; Familial Mediterranean Fever; Hepatoblastoma; Humans; Inflammation; Liver Neoplasms; MicroRNAs | 2023 |
The effect of immunomodulatory drugs on aortic stenosis: a Mendelian randomisation analysis.
Topics: Aortic Valve Stenosis; C-Reactive Protein; Colchicine; Genome-Wide Association Study; Humans; Immunomodulating Agents; Inflammation; Mendelian Randomization Analysis; Polymorphism, Single Nucleotide | 2023 |
Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-κB/NLRP3 pathways in inflammatory endothelial cells.
Topics: Animals; Atherosclerosis; Colchicine; Endothelial Cells; Inflammation; Mice; Nanoparticles; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Plaque, Atherosclerotic | 2023 |
Colchicine inhibits endothelial inflammation via NLRP3/CRP pathway.
Topics: Colchicine; Humans; Inflammasomes; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein | 2019 |
The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.
Topics: Age of Onset; Asymptomatic Diseases; Blood Sedimentation; C-Reactive Protein; Child; Colchicine; Correlation of Data; Familial Mediterranean Fever; Female; Humans; Inflammation; Longitudinal Studies; Male; Patient Acuity; Serum Amyloid A Protein; Sex Factors; Symptom Flare Up; Tubulin Modulators; Turkey | 2021 |
Inflammation as a Treatment Target after Acute Myocardial Infarction.
Topics: Colchicine; Humans; Inflammation; Myocardial Infarction | 2019 |
From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents?
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atherosclerosis; C-Reactive Protein; Colchicine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1beta; Interleukin-6; Lipid Metabolism; Methotrexate; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction | 2020 |
Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Anticholesteremic Agents; Cholesterol, LDL; Colchicine; Combined Modality Therapy; Coronary Artery Disease; Humans; Hypercholesterolemia; Inflammation; Myocardial Infarction; RNA, Small Interfering | 2020 |
Effect of combined colchicine-corticosteroid treatment on neutrophil/lymphocyte ratio: a predictive marker in Behçet disease activity.
Topics: Adrenal Cortex Hormones; Adult; Behcet Syndrome; Biomarkers; Colchicine; Female; Humans; Inflammation; Interferon-gamma; Interleukin-4; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Neutrophils; Nitric Oxide; Prognosis | 2020 |
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care?
Topics: Colchicine; Coronary Artery Disease; Humans; Inflammation; Percutaneous Coronary Intervention | 2020 |
Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review.
Topics: Aged; Colchicine; Familial Mediterranean Fever; Homozygote; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Leukopenia; Male; Mesothelioma; Peritoneum; Polymorphism, Genetic; Pyrin; Tomography, X-Ray Computed | 2020 |
How effective and safe are the interventions reducing inflammation in familial Mediterranean fever? A Cochrane Review summary with commentary.
Topics: Colchicine; Familial Mediterranean Fever; Gout Suppressants; Humans; Inflammation; Treatment Outcome | 2020 |
Total Burden of Events: A New Standard Stressing the Positive Impact of Inflammation Modulation.
Topics: Cardiovascular Diseases; Colchicine; Humans; Inflammation; Interleukin-1beta; Reference Standards | 2020 |
[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Humans; Inflammation; Methotrexate; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Translational Research, Biomedical | 2020 |
Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
Topics: Acute Coronary Syndrome; Angina, Stable; Anti-Inflammatory Agents; Colchicine; Extracellular Traps; Female; Humans; In Vitro Techniques; Inflammation; Male; Middle Aged; Myocardial Infarction; Neutrophil Activation; Neutrophils; Percutaneous Coronary Intervention; Treatment Outcome | 2021 |
Recurrent pericarditis: an update on diagnosis and management.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Humans; Inflammation; Neoplasms; Pericarditis; Pharmaceutical Preparations; Recurrence | 2021 |
Lessons learned from large Cardiovascular Outcome Trials targeting inflammation in cardiovascular disease (CANTOS, CIRT, COLCOT and LoDoCo2).
Topics: Atherosclerosis; Cardiovascular Diseases; Colchicine; Humans; Inflammation | 2021 |
Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation.
Topics: Animals; Anti-Inflammatory Agents; Calcium Carbonate; Colchicine; Cytokines; Disease Models, Animal; Inflammation; Myocardial Infarction; Nanoparticles; Rats | 2022 |
Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression.
Topics: Animals; Ankle; Anti-Inflammatory Agents; Antioxidants; Colchicine; Cytokines; Gout; Grape Seed Extract; Inflammation; Lipopolysaccharides; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; p38 Mitogen-Activated Protein Kinases; Pain; Phosphorylation; Proanthocyanidins; Reactive Oxygen Species; Signal Transduction; Spinal Cord; Uric Acid | 2017 |
A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy.
Topics: Abdominal Pain; Adult; Age of Onset; Colchicine; Delayed Diagnosis; Endemic Diseases; Familial Mediterranean Fever; Female; Genetic Testing; Humans; Inflammation; Italy; Male; Quality of Life; Serum Amyloid A Protein; Severity of Illness Index; Time Factors; Tubulin Modulators | 2017 |
Sweet's syndrome: a clinical entity need to discriminate against acute haematogenous periprosthetic joint infection.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthroplasty, Replacement, Knee; Colchicine; Diagnosis, Differential; Female; Humans; Ibuprofen; Inflammation; Knee Joint; Prosthesis-Related Infections; Sweet Syndrome | 2018 |
Will Reducing Inflammation Reduce Vascular Event Rates?
Topics: Acute Coronary Syndrome; Colchicine; Coronary Angiography; Humans; Inflammation; Tomography, X-Ray Computed | 2018 |
Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center.
Topics: Academic Medical Centers; Adrenal Cortex Hormones; Adult; Aged; Anemia; Arthralgia; Colchicine; Dapsone; Female; Filgrastim; fms-Like Tyrosine Kinase 3; Folic Acid Antagonists; Hematologic Agents; Humans; Inflammation; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged; Mutation; Neoplasms; Nuclear Proteins; Nucleophosmin; Potassium Iodide; Retrospective Studies; Sweet Syndrome; Tertiary Care Centers; Thrombocytopenia; Tubulin Modulators | 2018 |
Prophylactic use of colchicine in preventing radiation induced coronary artery disease.
Topics: Anti-Inflammatory Agents; Blood Platelets; Breast Neoplasms; Colchicine; Coronary Artery Disease; Female; Humans; Inflammation; Mediastinum; Microtubules; Models, Theoretical; Plaque, Atherosclerotic; Platelet Aggregation; Radiation Injuries; Radiotherapy | 2018 |
Etoricoxib inhibits peripheral inflammation and alters immune responses in intracerebroventricular colchicine injected rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cyclooxygenase 2; Etoricoxib; Inflammation; Injections, Intraventricular; Male; Rats; Tubulin Modulators | 2018 |
Effects of colchicine on gingival inflammation, apoptosis, and alveolar bone loss in experimental periodontitis.
Topics: Alveolar Bone Loss; Animals; Apoptosis; Colchicine; Inflammation; Osteoprotegerin; Periodontitis; RANK Ligand; Rats; Rats, Wistar | 2018 |
Inhibitory effects of colchicine on inflammasomes.
Topics: Atherosclerosis; Colchicine; Humans; Inflammasomes; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein | 2018 |
Reply to: "Inhibitory effects of colchicine on inflammasomes".
Topics: Atherosclerosis; Colchicine; Humans; Inflammasomes; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein | 2018 |
Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.
Topics: Adult; Arthralgia; Colchicine; Drug Administration Schedule; Familial Mediterranean Fever; Female; Fever; Humans; Inflammation; Menstruation; Mutation; Pyrin; Remission Induction; Tubulin Modulators | 2018 |
Could blood products obtained from patients with familial Mediterranean fever have beneficial or harmful effects?
Topics: Blood Transfusion; Colchicine; Familial Mediterranean Fever; Female; Hereditary Autoinflammatory Diseases; Humans; Inflammation; Interleukin-1beta; Leukocytes, Mononuclear; Male | 2019 |
Autoinflammation Masquerading as Autoimmunity in an Adult with Heterozygous p.E250K PSTPIP1 Mutation.
Topics: Adaptor Proteins, Signal Transducing; Autoimmunity; Colchicine; Cytoskeletal Proteins; Female; Heterozygote; Humans; Inflammation; Kidney; Leukocyte L1 Antigen Complex; Liver; Middle Aged; Mutation; Proteinuria; Syndrome | 2019 |
The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction.
Topics: Biomarkers; C-Reactive Protein; Colchicine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Retrospective Studies; Time Factors; Treatment Outcome | 2019 |
The role of classical and alternative macrophages in the immunopathogenesis of herpes simplex virus-induced inflammation in a mouse model.
Topics: Animals; Behcet Syndrome; Colchicine; Disease Models, Animal; Inflammation; Interferon-gamma; Interleukin-4; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred ICR; Pentoxifylline; Phenotype; Simplexvirus | 2014 |
[Study of the anti-inflammatory action of colchicum derivaties: colchicine-colchicoside].
Topics: Anti-Inflammatory Agents; Autonomic Nervous System; Colchicine; Colchicum; Humans; Inflammation | 1960 |
Higher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patients.
Topics: Adult; Carboxypeptidase B2; Case-Control Studies; Colchicine; Familial Mediterranean Fever; Female; Fibrinolysis; Humans; Inflammation; Male; Mutation; Tubulin Modulators; Young Adult | 2014 |
Serum antimicrobial peptides in patients with familial Mediterranean fever.
Topics: Adolescent; Adult; alpha-Defensins; Antimicrobial Cationic Peptides; beta-Defensins; Cathelicidins; Child; Colchicine; Familial Mediterranean Fever; Female; Humans; Immunity, Innate; Inflammation; Male; Middle Aged | 2014 |
TLR2 and TLR4 gene expression levels and associated factors during acute attack and attack-free periods in familial Mediterranean fever.
Topics: Acute Disease; Adult; Case-Control Studies; Colchicine; Familial Mediterranean Fever; Female; Gene Expression Profiling; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Inflammation; Lipopolysaccharides; Male; Mutation; Polymorphism, Genetic; Prospective Studies; Toll-Like Receptor 2; Toll-Like Receptor 4; Treatment Outcome; Young Adult | 2015 |
Risk factors for subclinical inflammation in children with Familial Mediterranean fever.
Topics: Acute-Phase Reaction; Adolescent; Amyloidosis; Arthralgia; Arthritis; Asymptomatic Diseases; Child; Child, Preschool; Colchicine; Cytoskeletal Proteins; Erythema; Familial Mediterranean Fever; Female; Genotype; Humans; Infant; Inflammation; Logistic Models; Male; Multivariate Analysis; Myalgia; Pyrin; Retrospective Studies; Risk Factors; Sex Factors; Tubulin Modulators | 2015 |
[Mesothelioma and familial Mediterranean fever: A relationship?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Causality; Colchicine; Familial Mediterranean Fever; Female; Humans; Inflammation; Lebanon; Mesothelioma; Middle Aged; Organoplatinum Compounds; Pemetrexed; Peritoneum; Pleural Neoplasms; Serous Membrane | 2015 |
Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?
Topics: Adult; Aged; Alleles; Behcet Syndrome; Chromatography, High Pressure Liquid; Colchicine; Cytochrome P-450 CYP2C9; Cytokines; Down-Regulation; Female; Genotype; Humans; Imidazoles; Inflammation; Losartan; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Tetrazoles; Turkey | 2015 |
Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects.
Topics: Adult; Blood Platelets; Cardiotonic Agents; Cell Adhesion; Colchicine; Female; Healthy Volunteers; Humans; Inflammation; Male; Monocytes; Myocardial Ischemia; Neutrophils; Pilot Projects; Platelet Activation; Platelet Aggregation; Prospective Studies; Young Adult | 2016 |
The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.
Topics: Child; Child Development; Child, Preschool; Colchicine; Familial Mediterranean Fever; Female; Humans; Infant; Inflammation; Linear Models; Male; Prospective Studies; Severity of Illness Index; Turkey; Weight Gain | 2016 |
Rebamipide Suppresses Monosodium Urate Crystal-Induced Interleukin-1β Production Through Regulation of Oxidative Stress and Caspase-1 in THP-1 Cells.
Topics: Alanine; Ascorbic Acid; Caspase 1; Cell Line; Colchicine; Dexamethasone; Enzyme Activation; Gout; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; NAD; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Quinolones; Reactive Oxygen Species; Signal Transduction; Uric Acid; Vascular Cell Adhesion Molecule-1 | 2016 |
α-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol.
Topics: alpha-Defensins; Animals; Atherosclerosis; Cathepsins; Cholesterol; Colchicine; Endothelial Cells; Humans; Inflammation; Lipoproteins, LDL; Male; Mice; Mice, Transgenic; Multiprotein Complexes; Protein Processing, Post-Translational | 2016 |
Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-κB Activation.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Gouty; Cell Line; Chemokine CCL2; Colchicine; Cyclooxygenase 2; Flavonoids; Gout Suppressants; Hypoxanthine Phosphoribosyltransferase; Inflammation; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; Polyethylene Glycols; Reactive Oxygen Species; Signal Transduction; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Uric Acid; Vascular Endothelial Growth Factor A | 2015 |
Rheumatoid Arthritis Presenting as Acute Myopericarditis.
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Colchicine; Coronary Angiography; Diagnosis, Differential; Echocardiography; Heart; Humans; Indomethacin; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Pericarditis; Rheumatoid Factor; Troponin | 2016 |
Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation.
Topics: Adipose Tissue; Animals; Colchicine; Diabetes Mellitus, Type 2; Gout Suppressants; Humans; Immunity, Innate; Inflammasomes; Inflammation; Insulin Resistance; Macrophages; Metabolic Diseases; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Risk Factors | 2016 |
Dual Role of Vitamin C on the Neuroinflammation Mediated Neurodegeneration and Memory Impairments in Colchicine Induced Rat Model of Alzheimer Disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Ascorbic Acid; Colchicine; Hippocampus; Inflammation; Male; Memory; Mice; Oxidative Stress; Rats; Reactive Oxygen Species; Vitamins | 2016 |
Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
Topics: Adolescent; Child; Child, Preschool; Colchicine; Familial Mediterranean Fever; Female; Follow-Up Studies; Genetic Variation; Heterozygote; Homozygote; Humans; Infant; Inflammation; Male; Mutation; Phenotype; Recurrence; Retrospective Studies; Tubulin Modulators | 2017 |
Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation.
Topics: Animals; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colchicine; Fibrosis; Humans; Inflammation; Metabolic Syndrome; Models, Theoretical; Obesity; T-Lymphocytes, Cytotoxic | 2016 |
Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
Topics: Adult; Arginine; C-Reactive Protein; Case-Control Studies; Colchicine; Endothelium, Vascular; Familial Mediterranean Fever; Humans; Inflammation; Lipids; Male; Young Adult | 2008 |
Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet's disease mouse model.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Colchicine; Enzyme-Linked Immunosorbent Assay; Herpes Simplex; Inflammation; Male; Mice; Mice, Inbred ICR; NADPH Oxidases; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tubulin Modulators | 2008 |
Radial artery occlusion, a rare presentation of Behçet's disease.
Topics: Adrenal Cortex Hormones; Arterial Occlusive Diseases; Behcet Syndrome; Colchicine; Erythema Nodosum; Humans; Inflammation; Male; Middle Aged; Radial Artery; Tubulin Modulators; Uveitis; Vasculitis | 2008 |
M694V mutation may have a role in susceptibility to ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diclofenac; Drug Combinations; Female; Follow-Up Studies; Genetic Predisposition to Disease; Glucosamine; Gout Suppressants; Homozygote; Humans; Inflammation; Male; Mutation; Radiography; Spondylitis, Ankylosing; Sulfasalazine; Time Factors; Treatment Outcome; Young Adult | 2009 |
Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
Topics: Animals; Cell Movement; Cells, Cultured; Chemokine CCL2; Colchicine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Extracellular Matrix; Fibronectins; Inflammation; Intercellular Adhesion Molecule-1; Macrophages; Rats; RNA, Messenger; Streptozocin; Tubulin Modulators | 2009 |
Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.
Topics: Adolescent; Biomarkers; Blood Sedimentation; C-Reactive Protein; Child; Child, Preschool; Colchicine; Cytoskeletal Proteins; Familial Mediterranean Fever; Female; Follow-Up Studies; Humans; Inflammation; Male; Mutation; Prospective Studies; Pyrin; S100 Proteins; S100A12 Protein; Serum Amyloid A Protein; Treatment Outcome; Young Adult | 2010 |
Modulation of the cyclooxygenase pathway via inhibition of nitric oxide production contributes to the anti-inflammatory activity of kaempferol.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Colchicine; Dexamethasone; Dinoprostone; Exudates and Transudates; Inflammation; Kaempferols; Lysine; Male; Nitric Oxide; Nitrites; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Sulfonamides | 2010 |
Isolation and anti-inflammatory activity of colchicinoids from Gloriosa superba seeds.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Colchicine; Dose-Response Relationship, Drug; Drug Discovery; Edema; Inflammation; Liliaceae; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Wistar; Seeds | 2010 |
Thiocolchicoside exhibits anticancer effects through downregulation of NF-κB pathway and its regulated gene products linked to inflammation and cancer.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Colchicine; Down-Regulation; Electrophoretic Mobility Shift Assay; Humans; Inflammation; Neoplasms; NF-kappa B; Signal Transduction | 2010 |
Hyperuricaemia and gout.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diet; Gout; Gout Suppressants; Humans; Hyperuricemia; Immunity, Innate; Inflammation; Kidney; Membrane Transport Proteins; Standard of Care; Steroids; Uric Acid | 2011 |
Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug.
Topics: Animals; Bone Neoplasms; Bone Resorption; Cell Line; Colchicine; Enzyme Activation; Female; Humans; I-kappa B Kinase; Inflammation; Liliaceae; Male; Mice; NF-kappa B; Osteoclasts; Phytotherapy; RANK Ligand; Signal Transduction | 2012 |
Effect of colchicine on myocardial injury induced by Trypanosoma cruzi in experimental Chagas disease.
Topics: Analysis of Variance; Animals; Chagas Disease; Colchicine; Collagen; Cricetinae; Disease Models, Animal; Female; Fibrosis; Heart Ventricles; Inflammation; Matrix Metalloproteinase 2; Myocarditis; Myocardium; Trypanosoma cruzi; Tubulin Modulators | 2012 |
[The role of aldosterone and IL-6 in the pathogenesis of inflammation in familial Mediterranean fever].
Topics: Adult; Aldosterone; Amyloidosis; Colchicine; Familial Mediterranean Fever; Genotype; Humans; Inflammation; Interleukin-6; Middle Aged | 2012 |
Nitroxides attenuate carrageenan-induced inflammation in rat paws by reducing neutrophil infiltration and the resulting myeloperoxidase-mediated damage.
Topics: Aniline Compounds; Animals; Antioxidants; Carrageenan; Chemotaxis; Colchicine; Cyclic N-Oxides; Edema; Halogenation; Inflammation; Male; Neutrophil Infiltration; Neutrophils; Nitrogen Oxides; Oxidation-Reduction; Peroxidase; Rats; Rats, Wistar; Spin Labels | 2012 |
[Cardiac tamponade revealing an adult onset Still's disease].
Topics: Adult; Cardiac Tamponade; Colchicine; Drainage; Echocardiography; Female; Ferritins; Humans; Inflammation; Pericardiocentesis; Still's Disease, Adult-Onset | 2013 |
Soft coral-derived lemnalol alleviates monosodium urate-induced gouty arthritis in rats by inhibiting leukocyte infiltration and iNOS, COX-2 and c-Fos protein expression.
Topics: Animals; Anthozoa; Anti-Inflammatory Agents; Arthritis, Gouty; Colchicine; Cyclooxygenase 2; Edema; Inflammation; Leukocytes; Male; Nitric Oxide Synthase Type II; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Sesquiterpenes; Uric Acid | 2013 |
Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity.
Topics: Animals; Colchicine; Cyclosporine; Fibrosis; Gene Expression; Immunosuppressive Agents; Inflammation; Kidney; Macrophages; Male; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins | 2002 |
Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; CD3 Complex; Cell Line; Cells, Cultured; Colchicine; Cytokines; Down-Regulation; Female; Inflammation; Injections, Intraperitoneal; Interferon-gamma; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Phagocytosis; Protein Biosynthesis; Proteinase Inhibitory Proteins, Secretory; Proteins; Secretory Leukocyte Peptidase Inhibitor; Thymus Gland; Transfection; Tumor Necrosis Factor-alpha; Up-Regulation | 2003 |
[Effect of urethane, demecolcine and podophyllotoxin on experimental inflammation].
Topics: Colchicine; Demecolcine; Inflammation; Podophyllin; Podophyllotoxin; Podophyllum; Urethane | 1958 |
[THE ACUTE INFLAMMATION OF GOUT].
Topics: Colchicine; Gout; Humans; Inflammation; Pathology; Uric Acid; Uricosuric Agents | 1963 |
[EXPERIMENTAL INFLAMMATION INDUCED BY A HEPARIN ANALOG. A TEST OF ANTI-INFLAMMATORY ACTIVITY].
Topics: Amodiaquine; Anti-Allergic Agents; Anti-Inflammatory Agents; Aspirin; Chemistry, Pharmaceutical; Colchicine; Desoxycorticosterone; Dexamethasone; Heparin; Histamine H1 Antagonists; Hydrocortisone; Inflammation; Phenylbutazone; Prednisolone; Promethazine; Quinine; Rats; Research; Salicylates | 1964 |
THE EFFECT OF PRETREATMENT WITH COLCHICINE ON THE INFLAMMATORY RESPONSE TO MICROCRYSTALLINE URATE: A MODEL FOR GOUTY INFLAMMATION.
Topics: Biomedical Research; Blood Chemical Analysis; Colchicine; Dosage Forms; Drug Therapy; Gout; Humans; Hydrocortisone; Inflammation; Injections, Intra-Articular; Injections, Subcutaneous; Orotic Acid; Phenylbutazone; Skin Tests; Synovial Fluid; Toxicology; Uric Acid | 1965 |
[The influence of ethyl urethane, demecolcine and podophyllotoxin on experimental inflammation in rats].
Topics: Animals; Colchicine; Demecolcine; Inflammation; Podophyllin; Podophyllotoxin; Podophyllum; Rats; Urethane | 1960 |
A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic
Topics: Adult; Amyloidosis, Familial; Colchicine; Cytoskeletal Proteins; Diagnosis, Differential; DNA Mutational Analysis; Familial Mediterranean Fever; Female; Gout Suppressants; Humans; Inflammation; Kidney Diseases; Male; Middle Aged; Pedigree; Periodicity; Phenotype; Proteins; Pyrin; Spain | 2004 |
Colchicine decreases airway hyperreactivity after phosgene exposure.
Topics: Acetylcholine; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage; Colchicine; Drug Administration Schedule; Forced Expiratory Flow Rates; Inflammation; Inhalation Exposure; Injections, Intraperitoneal; Lung; Lung Injury; Male; Neutrophils; Phosgene; Rats; Rats, Sprague-Dawley | 2005 |
Possible effect of subclinical inflammation on daily life in familial Mediterranean fever.
Topics: Activities of Daily Living; Adolescent; Adult; Blood Sedimentation; Child; Child, Preschool; Colchicine; Familial Mediterranean Fever; Female; Hemoglobins; Humans; Inflammation; Leukocyte Count; Male; Surveys and Questionnaires | 2006 |
Gout-associated uric acid crystals activate the NALP3 inflammasome.
Topics: Animals; Calcium Pyrophosphate; Carrier Proteins; Caspase 1; Cell Line; Cells, Cultured; Chondrocalcinosis; Colchicine; Disease Models, Animal; Gout; Humans; Inflammation; Interleukin-1; Macrophages; Mice; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein; Peritonitis; Receptors, Interleukin-1; Uric Acid | 2006 |
Influence of ethanol on human T-lymphocyte migration.
Topics: Acetaldehyde; Cell Movement; Chemokines, C; Colchicine; Cyclic GMP; Depression, Chemical; Ethanol; Humans; In Vitro Techniques; Inflammation; Lymphocyte Activation; Lymphokines; Sialoglycoproteins; T-Lymphocytes | 1984 |
The release of leukotriene B4 during experimental inflammation.
Topics: Animals; Calcimycin; Chromatography, High Pressure Liquid; Colchicine; Dinoprostone; Inflammation; Leukocyte Count; Leukotriene B4; Male; Prostaglandins E; Rats; Rats, Inbred Strains; Thromboxane B2 | 1983 |
Colchicine in acute inflammation: stimulation of production of interleukin-1 and modulation of the acute phase serum amyloid A protein response.
Topics: Amyloid; Amyloidosis; Animals; Colchicine; Female; Inflammation; Interleukin-1; Macrophages; Mice; Mice, Inbred C3H; Mice, Inbred CBA; Serum Amyloid A Protein | 1984 |
Inflammatory reaction in familial Mediterranean fever (FMF) before and with colchicine therapy.
Topics: Adult; Aged; Amyloidosis; Colchicine; Complement C4; Complement System Proteins; Familial Mediterranean Fever; Female; Humans; Inflammation; Male; Middle Aged; Serum Globulins | 1984 |
The source of thromboxane and prostaglandins in experimental inflammation.
Topics: Animals; Blood Platelets; Colchicine; Exudates and Transudates; Inflammation; Leukocyte Count; Male; Neutropenia; Prostaglandins; Radioimmunoassay; Rats; Thrombocytopenia; Thromboxane B2; Thromboxanes | 1983 |
Enhanced polymorphonuclear chemotaxis - a common feature of diseases responsive to colchicine.
Topics: Arthritis; Behcet Syndrome; Chemotaxis, Leukocyte; Colchicine; Gout; Humans; Inflammation; Neutrophils | 1981 |
The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formation of I and 2 series prostaglandins: relevance to inflammation and immunity.
Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acids; Blood Platelets; Colchicine; Feedback; Humans; Immunity; Inflammation; Melatonin; Prostaglandins; Prostaglandins E; Thromboxane A2 | 1980 |
Modification of cholesterol crystal-induced inflammation.
Topics: Animals; Arthritis; Cholesterol; Colchicine; Crystallization; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Inflammation; Male; Prostaglandins; Rats; Uric Acid | 1980 |
Ozone-induced decrease of mouse tracheal potential is not secondary to cellular inflammation.
Topics: Animals; Bronchoalveolar Lavage Fluid; Colchicine; Cyclophosphamide; Electrophysiology; Epithelium; Indomethacin; Inflammation; Male; Mice; Mice, Inbred Strains; Neutrophils; Ozone; Proteins; Trachea | 1995 |
[Treatment of acute microcrystalline inflammation].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Colchicine; Crystallization; Humans; Inflammation | 1994 |
Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Colchicine; Dinoprostone; Homosteroids; Inflammation; Leukotriene B4; Male; Neutrophils; Peroxidase; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Sesterterpenes; Terpenes; Zymosan | 1996 |
Colchicine-induced elevation of tissue metallothionein contents is mediated by inflammation-independent serum factor.
Topics: Animals; Biological Factors; Colchicine; Gout Suppressants; Inflammation; Liver; Liver Neoplasms, Experimental; Male; Metallothionein; Mice; Mice, Inbred Strains; Stimulation, Chemical; Tumor Cells, Cultured; Zinc | 1997 |
Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch.
Topics: Animals; Blotting, Western; Colchicine; Dexamethasone; Eicosanoids; Enzyme Inhibitors; Female; Inflammation; Leukocytes; Nitric Oxide; Nitric Oxide Synthase; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Zymosan | 1997 |
Pain relief in familial Mediterranean fever.
Topics: Analgesia; Colchicine; Drug Administration Schedule; Familial Mediterranean Fever; Humans; Inflammation | 1997 |
Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases?
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 7; Colchicine; Familial Mediterranean Fever; Gout Suppressants; Humans; In Vitro Techniques; Inflammation; Leukocytes; Neutrophils; Rhodamines; Verapamil | 1998 |
Descending modulation of opioid-containing nociceptive neurons in rats with peripheral inflammation and hyperalgesia.
Topics: Animals; Blotting, Northern; Calcitonin Gene-Related Peptide; Colchicine; Denervation; Dynorphins; Enkephalins; Freund's Adjuvant; Ganglia, Spinal; Gene Expression; Hyperalgesia; Inflammation; Male; Neurons, Afferent; Nociceptors; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spinal Cord; Tachykinins | 1999 |
The effects of colchicine treatment on wound healing in a caustic murine injury model.
Topics: Animals; Burns, Chemical; Caustics; Colchicine; Female; Fibrosis; Inflammation; Mice; Neovascularization, Physiologic; Sodium Hydroxide; Wound Healing | 1999 |
Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Colchicine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Eicosanoids; Enzyme Induction; Exudates and Transudates; Female; Fluorescent Antibody Technique; Inflammation; Isoenzymes; Leukocytes; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Time Factors; Zymosan | 2000 |
Temporal profile of release of interleukin-1beta in neurotrauma.
Topics: Animals; Brain; Brain Injuries; Chloroquine; Colchicine; Immunohistochemistry; Inflammation; Interferon-gamma; Interleukin-1; Lipopolysaccharides; Male; Microdialysis; Microglia; Rats; Rats, Wistar; RNA, Messenger; Serpins; Time Factors; Viral Proteins | 2000 |
Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis.
Topics: Age of Onset; Amyloidosis; Colchicine; Environment; Familial Mediterranean Fever; Genotype; Humans; Inflammation; Mutation; Residence Characteristics | 2000 |
[A case of cervical calcinosis].
Topics: Aged; Cervical Vertebrae; Chondrocalcinosis; Colchicine; Female; Gout Suppressants; Humans; Inflammation; Morphine; Pain; Radiography | 2000 |
Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity.
Topics: Afferent Pathways; Animals; Axonal Transport; Capsaicin; Colchicine; Functional Laterality; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Inflammation; Male; Nerve Endings; Oligodeoxyribonucleotides, Antisense; Pain; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Drug; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sciatic Nerve; Transcription, Genetic | 2001 |
Prevalence of ischemic heart disease in patients with familial Mediterranean fever.
Topics: Adult; Case-Control Studies; Colchicine; Familial Mediterranean Fever; Female; Gout Suppressants; Humans; Inflammation; Israel; Male; Middle Aged; Myocardial Ischemia; Prevalence; Registries; Risk Factors; Smoking; Surveys and Questionnaires | 2001 |
Mechanism of anti-inflammatory action of glucocorticosteroids.
Topics: Adenylyl Cyclases; Animals; Anti-Inflammatory Agents; Cell Movement; Colchicine; Culture Techniques; Cyclic AMP; Glucocorticoids; Guinea Pigs; Humans; Inflammation; Intracellular Fluid; Phagocytes; Vinblastine | 1977 |
Mechanism of action of colchicine. I. Effect of colchicine and its analogs on the reversed passive Arthus reaction and the carrageenan-induced hindpaw edema in the rat.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthus Reaction; Carrageenan; Colchicine; Dose-Response Relationship, Drug; Edema; Gout; Inflammation; Injections, Intraperitoneal; Injections, Intravenous; Male; Microtubules; Rats | 1975 |
[Pharmacologic study of inflammatory processes. Modification of polynuclear neutrophil chemotaxis].
Topics: Animals; Calcium Pyrophosphate; Carrageenan; Chemotaxis, Leukocyte; Cholera Toxin; Colchicine; Freund's Adjuvant; Immunosuppressive Agents; In Vitro Techniques; Inflammation; Neutrophils; Prostaglandins; Rats | 1979 |
Anti-prostaglandin action of colchicine.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; Diphosphates; Inflammation; Male; Prostaglandin Antagonists; Prostaglandins E; Rats; Time Factors; Uric Acid | 1975 |
Mechanisms by which leukocytes emigrate and induce tissue destruction.
Topics: Animals; Antigen-Antibody Complex; Carrageenan; Cell Movement; Chemotaxis; Chromium Radioisotopes; Colchicine; Exudates and Transudates; Hydrocortisone; Inflammation; Leukocytes; Microbial Collagenase; Models, Biological; Peptide Hydrolases; Phagocytosis; Phenylbutazone; Rabbits; Rats; Snake Venoms | 1976 |
In-vivo effects of anti-inflammatory and other drugs on granulocyte emigration in the rabbit skin collection chamber.
Topics: Animals; Anti-Inflammatory Agents; Cell Movement; Colchicine; Cyclophosphamide; Female; Granulocytes; Inflammation; Rabbits; Skin Window Technique | 1978 |
Effects of colchicine on the microvascular endothelium in response to acute inflammation.
Topics: Animals; Carrageenan; Colchicine; Cytoplasm; Endothelium; Inflammation; Male; Microcirculation; Pseudopodia; Rats; Vacuoles | 1979 |
Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.
Topics: Animals; C-Reactive Protein; Colchicine; Inflammation; Liver; Rabbits; Turpentine | 1978 |
[The therapeutic year].
Topics: Albuterol; Anti-Inflammatory Agents; Aspirin; Calcitonin; Colchicine; Drug Therapy; Endocrine System Diseases; Familial Mediterranean Fever; Female; Geriatrics; Humans; Inflammation; Lithium; Obstetric Labor, Premature; Osteitis Deformans; Pituitary Hormone-Releasing Hormones; Pituitary Hormones; Pregnancy; Risk; Somatostatin; Thromboembolism; Thyroid Hormones | 1976 |
Experimental inflammation induced by naturally occurring microcrystalline calcium salts.
Topics: Animals; Anti-Inflammatory Agents; Calcium; Calcium Phosphates; Carrageenan; Colchicine; Copper; Disease Models, Animal; Freund's Adjuvant; Indomethacin; Inflammation; Male; Phenylbutazone; Rats; Uric Acid | 1976 |
A comparison of the anti-inflammatory activity of selective 5-lipoxygenase inhibitors with dexamethasone and colchicine in a model of zymosan induced inflammation in the rat knee joint and peritoneal cavity.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arthritis; Benzeneacetamides; Calcimycin; Colchicine; Dexamethasone; Dinoprostone; Disease Models, Animal; Hydroxamic Acids; Inflammation; Kinetics; Knee Joint; Leukocytes; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Male; Peritonitis; Pyrazoles; Rats; Zymosan | 1991 |
Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis.
Topics: Animals; Ascites; Capillary Permeability; Chemotaxis, Leukocyte; Colchicine; Drug Interactions; Imidazoles; Inflammation; Injections, Intraperitoneal; Leukotriene B4; Male; Mice; Mice, Inbred BALB C; Neutrophils; Peritonitis; Pyrazoles; SRS-A; Thiazoles | 1991 |
Pharmacological investigation of acute cellular accumulation in immunological air pouch inflammation.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Antigens; Aprotinin; Bromelains; Cimetidine; Colchicine; Cromolyn Sodium; Cyproheptadine; Elapid Venoms; Immune Sera; Indomethacin; Inflammation; Leukocytes; Male; Neutrophils; Prednisolone; Pyrazoles; Rats; T-Lymphocytes | 1989 |
Regulation of macrophage collagenase, prostaglandin, and fibroblast-activating-factor production by anti-inflammatory agents: different regulatory mechanisms for tissue injury and repair.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; Cyclic AMP; Dexamethasone; Dinoprostone; Fibroblast Growth Factors; Fibroblasts; Guinea Pigs; Indomethacin; Inflammation; Macrophages; Microbial Collagenase; Prostaglandins E; Wound Healing | 1985 |
Crystal-induced inflammation in the rat subcutaneous air-pouch.
Topics: Animals; Anti-Inflammatory Agents; Calcium Pyrophosphate; Colchicine; Diphosphates; Disease Models, Animal; Inflammation; Leukotriene B4; Male; Neutrophils; Rats; Rats, Inbred Strains; Uric Acid | 1987 |
Studies of eicosanoid production in the air pouch model of synovial inflammation.
Topics: 6-Ketoprostaglandin F1 alpha; Air; Animals; Carrageenan; Colchicine; Dinoprostone; Disease Models, Animal; Female; Fluorouracil; Inflammation; Kinetics; L-Lactate Dehydrogenase; Neutrophils; Pertussis Vaccine; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Synovial Fluid | 1986 |
Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
Topics: Amyloid; Amyloidosis; Animals; Colchicine; Female; Glycoproteins; Growth Substances; Inflammation; Kinetics; Mice; Mice, Inbred Strains; Serum Amyloid A Protein; Silver Nitrate; Spleen | 1985 |
Cryoglobulin-induced inflammation.
Topics: Alprostadil; Animals; Choline; Colchicine; Cryoglobulins; Crystallization; Dipyridamole; Drug Combinations; Fatty Acids, Essential; Inflammation; Male; Rats; Rats, Inbred Strains; Salicylates | 1985 |
Polymorphonuclear leukocyte motility in vitro. V. Release of chemotactic activity following phagocytosis of calcium pyrophosphate crystals, diamond dust, and urate crystals.
Topics: Animals; Calcium Phosphates; Carbon; Chemotaxis; Colchicine; Crystallography; Diphosphates; Dogs; Humans; In Vitro Techniques; Inflammation; Injections, Intra-Articular; Leukocytes; Phagocytosis; Uric Acid | 1970 |
Leukocytes as secretory organs of inflammation.
Topics: Atropine; Blood Platelets; Bucladesine; Carbachol; Cell Survival; Cells, Cultured; Colchicine; Cyclic AMP; Cyclic GMP; Deuterium; Epinephrine; Glucuronidase; Histamine; Humans; Inflammation; Isoproterenol; Leukocytes; Lymphocytes; Monocytes; Peroxidases; Phenylephrine; Prostaglandins; Theophylline | 1973 |
Leukocyte chemotaxis in vivo. II. Analysis of the selective inhibition of neutrophil or mononuclear cell accumulation.
Topics: Animals; Bucladesine; Carrageenan; Chemotaxis; Chloroquine; Chlorpromazine; Chromium Radioisotopes; Clonidine; Colchicine; Cyclophosphamide; Female; Flufenamic Acid; Indomethacin; Inflammation; Leukocyte Transfusion; Leukocytes; Methylprednisolone; Monocytes; Neutrophils; Phenylbutazone; Rats; Transplantation, Homologous; Venoms; Vinblastine | 1974 |
The formation and properties of macrophage polykaryons (inflammatory giant cells).
Topics: Acid Phosphatase; Animals; Autoradiography; Cell Fusion; Cell Nucleus; Cell Survival; Chromosomes; Colchicine; Histocytochemistry; Inflammation; Karyotyping; Macrophages; Male; Mice; Microscopy, Electron; Microscopy, Electron, Scanning; Mitosis; Phagocytosis; RNA; Succinate Dehydrogenase; Thymidine; Tritium; Uridine | 1974 |
[The kinins].
Topics: Angioedema; Animals; Blood Coagulation Factors; Bradykinin; Carboxypeptidases; Carcinoid Tumor; Catecholamines; Chemical Phenomena; Chemistry; Colchicine; Complement System Proteins; Female; Glucocorticoids; Guinea Pigs; Haplorhini; Humans; Inflammation; Kallidin; Kallikreins; Kidney; Kinins; Muscle Contraction; Phenothiazines; Rats; Salicylates; Sheep; Shock, Septic; Stimulation, Chemical; Uterus; Vascular Diseases; Vascular Resistance; Vasodilator Agents | 1969 |
Pathogenesis and treatment of the acute attack of gout.
Topics: Acute Disease; Animals; Calculi; Colchicine; Crystallization; Dogs; Gout; Humans; Inflammation; Leukocytes; Neutrophils; Synovial Fluid; Uric Acid | 1970 |
Effects of colchicine in rats with urate crystal-induced inflammation.
Topics: Adrenal Glands; Animals; Body Weight; Colchicine; Crystallization; Edema; Gout; Inflammation; Male; Mitosis; Organ Size; Phosphorus; Phosphorus Isotopes; Podophyllin; Rats; Spleen; Sulfur; Sulfur Isotopes; Thymus Gland; Toxins, Biological; Uric Acid | 1970 |
Interaction of carbohydrates and anti-inflammatory drugs with mast cells in the rat.
Topics: Animals; Anti-Inflammatory Agents; Carbohydrates; Colchicine; Depression, Chemical; Dextrans; Drug Antagonism; Histamine Release; Hydrocortisone; Inflammation; Mast Cells; Mechlorethamine; Mucoproteins; p-Methoxy-N-methylphenethylamine; Peritoneum; Phenylbutazone; Polysaccharides; Rats; Sodium Salicylate | 1968 |
The interaction of leukocytes and the kinin system.
Topics: Bradykinin; Carboxypeptidases; Colchicine; Depression, Chemical; Eosinophils; Factor XII; Glucocorticoids; Humans; Hydrogen-Ion Concentration; Inflammation; Kallikreins; Kinins; Leukemia; Leukocytes; Lymphocytes; Models, Biological | 1968 |
The action of colchicine in acute gout.
Topics: Chemotaxis; Colchicine; Gout; In Vitro Techniques; Inflammation; Leukocytes | 1965 |
Colchicine inhibition of chemotaxis.
Topics: Chemotaxis; Colchicine; Humans; In Vitro Techniques; Inflammation; Leukocytes | 1965 |